Technically speaking, yes. But from a more hybrid basis (fundamentals included) I really think this one will run. The ER was phenomenal. And Zohydro ER is just getting started, since it was just approved in March.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.